This is a company that was once the most popular IPO in 2021 and at the peak of the speciality chemicals cycle. The IPO was oversubscribed over 180x. Yes. 180x
The scrip got listed at 21x Mcap/Sales, 15x PB and 90x PE.
But now, we believe that the worst is behind us. How? Let’s start with the study.
About the company
Tatva Chintan Pharma Chem Ltd, Mcap 2800 Cr, is in the business of manufacturing speciality chemicals.
Incorporated in 1996. Completed 30 years in the business.
Business Model
To understand the product categories better, let’s look at a simple chemical reaction to get the terminology.
To read the full article, please subscribe to PRUDENT Ideas Membership!
See you next time.
Until then… Stay Prudent!
Disclaimer: This article is provided for informational purposes only and should not be considered as an investment advice
Also Read: